Analysis and Perspectives

Apr 22, 2022

Several leading pharma companies are evaluating their emerging therapies in the Knee Osteoarthritis Market. Centrexion, Biosplice, Regeneron,

Apr 20, 2022

Zokinvy, Danyelza, Myalept, Luxturna, and Folotyn are among the most expensive drugs in the US Healthcare Market. Prescription drugs costs

Apr 13, 2022

Metaverse in Healthcare is gaining significant attention from healthcare providers, patients, and MedTech giants. Metaverse applications and

Apr 11, 2022

Ankylosing Spondylitis Treatment Landscape to evolve with the active participation of pharma companies developing new therapies for the

Apr 08, 2022

Chronic Obstructive Pulmonary Disease (COPD) prevalence is increasing drastically in recent years due to higher smoking prevalence, aging and

Apr 04, 2022

The development of targeted LAG-3 immunotherapy is anticipated to revolutionize cancer treatment in the coming years, companies in the market

Apr 01, 2022

Treatment-resistant Hypertension (RHTN) is known to be associated with higher rates of major adverse cardiovascular disease events.

Mar 30, 2022

Some of the leading blockbuster drugs are expected to lose patent protection in 2022 which include Revlimid, Lucentis, Vimpat, Alimta

Mar 28, 2022

Fabry Disease treatment market is continuously evolving due existence of new therapies as well as key pharmaceuticals involved

Mar 11, 2022

Nerve Repair and Regeneration Market is anticipated to grow at a medium pace, attributed to factors such as increasing demand and incidence.